For instance, ubiquilin 2 (UBQLN2), which plays a role in the ubiquitin proteasome system and mutations are associated with FTD, enhanced the activation of NFKB activity through MAPK signaling resulting in TDP-43 aggregation in vitro [47]. The gene discussed is NFKB1; the disease is frontotemporal dementia.